Why Bone Density Drops After Menopause: The Estrogen Rebuild-Signal Explained

The common story is only half right

Ask most people why women lose bone after menopause and they will say calcium. Drink your milk, take your supplement, and you will hold onto your bones. It is not wrong exactly, but it describes the bricks while missing the foreman.

Bone is not a static block of mineral. It is living tissue in constant renovation. Every day, cells called osteoclasts break a little bone down and cells called osteoblasts build a little back. For most of adult life those two crews stay roughly in balance, and your bone density holds.

Estrogen was the manager keeping that balance. It quietly restrained the breakdown crew and kept the building crew working. That is the piece the calcium story leaves out. Calcium is the material. Estrogen was the instruction to keep using it.

What actually happens when estrogen falls

At menopause estrogen drops sharply, and the restraint on the breakdown crew comes off.

Now the osteoclasts work faster than the osteoblasts can keep up. Bone comes apart quicker than it goes back together, and the net result is loss. This is why the steepest bone loss of a woman's life happens in the years right around and after her final period, not slowly across decades but in a concentrated window.

You can pour in all the calcium you like, and it helps supply the raw material. What it cannot do is restore the instruction that tells the body to keep laying that material down. That is the signal that went quiet, and it is the reason a woman doing everything right can still watch her numbers fall.

The rebuild signal, step by step

The clearest way to see it is as a chain.

Where shilajit fits, and why it is not a hormone

This is the exact point where shilajit enters the picture, because it works on the signal rather than the supply.

Shilajit is a purified mineral resin from the Altai mountains, standardized for its fulvic acid content. It is not a hormone and does not add estrogen to your body. What the research shows is that it supports the body's own estrogen signaling and shifts the balance between bone breakdown and bone building. That distinction matters. You are not replacing a hormone. You are helping the body hear an instruction it stopped hearing.

The human trial made this concrete. Published in 2022 in the journal Phytomedicine by Pingali and Nutalapati, it ran 48 weeks in 60 postmenopausal women with low bone mass, randomized, double blind, and placebo controlled. The placebo group kept losing bone. Both shilajit groups, at 250 mg and 500 mg a day, preserved and increased their density, and every woman who took it reversed her osteopenia.

There is a second piece of human evidence worth adding here. A 2020 double-blind randomized controlled trial in 160 people (Sadeghi and colleagues) found that oral shilajit, known regionally as momiai, cut the average tibial-fracture healing time to about 129 days versus 153 days on placebo, roughly 24 days faster https://pubmed.ncbi.nlm.nih.gov/32310691/. That is human evidence of shilajit actively supporting bone rebuilding, not just slowing loss.

Reading the signal shift in the blood

The trial did not stop at the scan. It measured the signal itself through markers in the blood, which is what makes the rebuild-signal explanation more than a metaphor.

CTX-1 marks bone being torn down. On placebo it rose. In the 500 mg group it fell by about 22 percent. Then the two signals that work as a pair, RANKL and OPG. RANKL tells the body to break bone down. OPG protects bone from that order. On 500 mg of shilajit, OPG rose by about 57 percent and the whole RANKL to OPG ratio fell by about 42 percent. The instruction to dismantle bone came down, and the instruction to protect and rebuild it went up.

There is a second layer too. When estrogen falls, low grade inflammation and oxidative stress rise, and both quietly speed bone loss. In the trial, the inflammation marker hsCRP fell by about 30 percent in the higher dose group, the oxidative damage marker MDA fell by about 20 percent, and the body's master antioxidant GSH rose by about 37 percent. So the shilajit was turning down the background fire and rust that were feeding the loss, not only changing the direct bone signal.

Why the mechanism underneath holds up

A human trial is more convincing when the laboratory and animal work agree with it, so here is what sits underneath, labeled honestly.

In cell research, Kangari and colleagues in 2022 found shilajit accelerated the maturation of human stem cells into bone building cells. Abbasi and colleagues in 2019 found a low dose of shilajit raised the proliferation of osteoblast-like cells. In ovariectomized rats, a standard menopause model, shilajit improved bone density and lowered turnover markers. None of these replace the human result. They explain why it happened.

Safety, purity, and the honest frame

The safety read in the trial was clean. All blood safety labs stayed normal and no woman discontinued for a side effect. Across every human shilajit study ever done, zero serious adverse events have been reported.

Optimum shilajit comes from the Altai mountains, independent third party lab tested, heavy metal free, and Prop 65 compliant in California. We are a small, family owned company out of Florida. It comes as a box of tablets.

What this means for you

If your scan is drifting despite doing the calcium-and-exercise routine, this is likely why. The problem was never only the bricks. It was the signal that told your body to keep building with them, and that signal fell when your estrogen did. Shilajit works on that signal, and in the one human trial run on women in your position, the direction of the scan changed.

References

1. Pingali U, Nutalapati C. Shilajit extract reduces oxidative stress, inflammation, and bone loss to dose-dependently preserve bone mineral density in postmenopausal women with osteopenia: A randomized, double-blind, placebo-controlled trial. Phytomedicine. 2022;105:154334. https://pubmed.ncbi.nlm.nih.gov/35933897/
2. Kangari P, et al. Shilajit accelerates osteogenic differentiation of human adipose-derived stem cells. 2022. https://pubmed.ncbi.nlm.nih.gov/36153551/
3. Abbasi A, et al. Effect of mumie on proliferation of osteoblast-like cells. 2019. https://pubmed.ncbi.nlm.nih.gov/31983854/
4. Alshubaily F, et al. Antioxidant and anti-osteoporotic activities of shilajit-loaded chitosan nanoparticles in rats. 2022. https://pubmed.ncbi.nlm.nih.gov/36235920/
5. Stohs SJ. Safety and efficacy of shilajit (mumie, moomiyo). Phytotherapy Research. 2014. https://pubmed.ncbi.nlm.nih.gov/23733436/
6. Sadeghi SMH, et al. "The effect of momiai (shilajit) on fracture healing: a randomized, double-blind, placebo-controlled clinical trial." 2020. n=160; healing time about 129 days vs 153 days on placebo. PMID 32310691. (Paywalled, URL cited.)